MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

Pyros Pharma announces VIGPODER™ (vigabatrin)

01 Apr 2024

Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced...

Medtronic, Heart-Valve-Surgery.Com launch 'Aortic Stenosis Patient Activation Platform

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

To Revolutionize Coronary Artery Bypass Surgery, AMT Medical Secures $25 Million in Series B Funding

Abcentra LLC Commences Phase 2b 'FORTIFY' Trial with First Patient Dosed, Evaluating Orticumab for Cardiovascular Disease

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

By Beauty Crush Skincare
Beauty Crush Skincare
04 Jun 2026

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

By Brain Navi Biotechnology
Brain Navi Biotechnology
04 Jun 2026

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

By SK bioscience
SK bioscience
03 Jun 2026

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

By Niagen Bioscience, Inc
Niagen Bioscience, Inc
03 Jun 2026

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

By Medella Springs
Medella Springs
02 Jun 2026

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

By Seegene
Seegene
02 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

Peer-reviewed validation of a 60-channel closed-loop neurostimulation brain implant is published by Nia Therapeutics

By Nia Therapeutics

Jan 04
Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

By Menarini Industrie Farmaceutiche Riunite

Nov 25
ProductLife Group Appoints Dr. James Burt as CEO

By ProductLife Group

Mar 24

June 2026

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

Pyros Pharma announces VIGPODER™ (vigabatrin)

Medtronic, Heart-Valve-Surgery.Com launch 'Aortic Stenosis Patient Activation Platform

Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults

To Revolutionize Coronary Artery Bypass Surgery, AMT Medical Secures $25 Million in Series B Funding

Abcentra LLC Commences Phase 2b 'FORTIFY' Trial with First Patient Dosed, Evaluating Orticumab for Cardiovascular Disease

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Most Popular

Peer-reviewed validation of a 60-channel closed-loop neurostimulation brain implant is published by Nia Therapeutics

Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

ProductLife Group Appoints Dr. James Burt as CEO

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter